Asset Management and Custody Banks

Hamilton Lane 

Hamilton Lane to Release FY2026 Q4 Earnings on May 21 Pre-Market EST, Forecast Revenue USD 203.25 M, EPS USD 1.43

JPMorgan Raises Hamilton Lane's Stock Rating to 'Overweight'

Artisan Partners Increased Holdings in Hamilton Lane to $42.88 million

Hamilton Lane Inc. Co-Chairman Acquires Company's Common Stock

Hamilton Lane Leads $500 Million Investment in VFN Holdings

Hamilton Lane Announces $50 Million Buyback Program

Hamilton Lane released FY2026 Q3 earnings on February 3, Pre-Market EST, with actual revenue of USD 198.59 M (forecast USD 195.52 M) and actual EPS of USD 1.3692 (forecast USD 1.27)

Hamilton Lane released FY2026 9 Months earnings on February 3 Pre-Market (EST), actual revenue USD 565.43 M, actual EPS USD 4.3425

Hamilton Lane Inc. Reports Q3 2026 Earnings, Revenue Exceeds Expectations

Hamilton Lane to release FY2026 Q3 earnings on February 3, Pre-Market EST, with forecast revenue of USD 195.52 M and EPS of USD 1.27

Hamilton Lane CEO Acquires Company's Common Stock

Hamilton Lane Inc Reports Strong Growth and Positive Outlook in Earnings Call

Hamilton Lane released FY2026 Semi-Annual earnings on November 4, Pre-Market (EST), actual revenue USD 366.84 M, actual EPS USD 2.9799

Hamilton Lane released FY2026 Q2 earnings on November 4 Pre-Market EST, actual revenue USD 190.88 M (forecast USD 169.44 M), actual EPS USD 1.6923 (forecast USD 1.12)

Hamilton Lane Inc. reports 29% YoY growth in Q2 net income

Hamilton Lane to Release FY2026 Q2 Earnings on November 4, Pre-Market EST; Forecast Revenue USD 169.44 M, EPS USD 1.09

Hamilton Lane Inc. Partners with KAIO to Tokenize SCOPE on Sei Network

Hamilton Lane Inc amends $75 million Term Loan Agreement

BMO Capital Markets Rates Hamilton Lane as Outperform

BMO Capital Markets Issues Buy Rating on Hamilton Lane

OPTIMI HEALTH CORP

HCW Biologics

Silexion Therapeutics

Vida Global

GCL Global

BiomX

MetaVia

Micware

MicroAlgo

Earning Release Date

财报预告

FY2026 Q4 Earning Release 2026.05.21 (EST) Pre-Market

HLNE

Hamilton Lane (HLNE) will announce its Q1 earnings this Thursday. Last quarter, it reported $198.6 million in revenue, an 18% year-on-year increase. This quarter, revenue is expected to grow by 1.2%. Analysts have maintained their estimates, indicating stability. Hamilton Lane's stock has declined 22.5% recently, with an average price target of $135.57 against a current price of $82.76.

Stock Story

Franklin Resources

Voya Financial

Amazon

Paypal

Meta Platforms

VOYA FINANCIAL INC 5.35% DEP SHS REP 1/40TH NON CUM SER B

Hamilton Lane (HLNE) Q1 Earnings Report Preview: What To Look For

Hamilton Lane (HLNE) has launched new interval funds, attracting over $350 million in commitments. Despite a recent share price of $92.41, the stock has seen a 34.47% decline over 90 days and a 40.40% drop over the past year. Analysts suggest a fair value of $138.14, indicating potential undervaluation. The company reports strong growth in its Evergreen platform, but risks from regulation and competition remain. Investors are encouraged to assess the balance of opportunity and risk in light of these developments.

Simplywall

Assessing Hamilton Lane (HLNE) Valuation As New Interval Funds And Tokenization Expand Growth Channels

Oppenheimer & Co. Inc. has acquired a new stake in Hamilton Lane Inc. (NASDAQ:HLNE), purchasing 17,332 shares valued at approximately $2.33 million. Other institutional investors have also increased their holdings in Hamilton Lane. Analysts have issued mixed ratings, with Oppenheimer lowering its price target from $230 to $171, while JPMorgan upgraded the stock to 'overweight' with a target of $166. Hamilton Lane's stock is currently trading at $91.12, with a market cap of $5.08 billion and a P/E ratio of 16.36. The company reported strong earnings, exceeding estimates with a revenue increase of 18% year-over-year.

Market Beat

Oppenheimer

UBS Group AG

JPMorgan Chase

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

Oppenheimer & Co. Inc. Takes Position in Hamilton Lane Inc. $HLNE

MidOcean Announces Successful Close of Single-Asset Continuation Vehicle for Cloyes | HLNE Stock News

StockTitan

MidOcean Announces Successful Close of Single-Asset Continuation Vehicle for Cloyes | HLNE Stock News

Asia-focused private equity (PE) funds are attracting investor interest as their distributions outperformed global averages in 2025, achieving 8% compared to the 7% global average. This trend has been consistent, with Asia PE funds outperforming in four of the last five years, underscoring the region's appeal for diversification. Collwyn Tan from Hamilton Lane noted that the total distributions are nearing a record year, marking the second-highest in history.

Businesstimes News

Asia private equity draws fresh investor interest as returns beat global averages, despite fundraising headwinds

Shares of Hamilton Lane Inc (NASDAQ:HLNE) fell 5.67% to $89.46 following a short report by Hunterbrook Media, which raised concerns about the firm's valuation practices and fee structures. The report alleges that Hamilton Lane inflates earnings through "day-one markups" on secondary assets, leading to a 37% boost in reported fee-related earnings. Hunterbrook warns that the firm's financial model is at risk if retail investor withdrawals increase, citing a $172 million net outflow from one of its evergreen funds in March.

benzinga_article

Hamilton Lane Shares Slide Following Hunterbrook Short Report

ZETA

The U.S. market has risen 3.4% in the past week and 35% over the last year, with earnings expected to grow by 16% annually. Notable undervalued stocks include Hamilton Lane (HLNE), trading at $105.12 with a 48.5% discount to its fair value of $204.09; Robert Half (RHI), priced at $27.59 with a 49.4% discount to $54.57; and Zeta Global Holdings (ZETA), at $17.37 with a 42.4% discount to $30.13. These companies show potential for growth despite current market conditions.

Zeta Global

Robert Half

WesBanco

Vertex

Nutanix

DNOW

Commvault Systm

Coastal Financial Washington

Clear Secure

BioHarvest Sciences

Ategrity Specialty Holdings LLC

Wesbanco Pref Shares 7.375 WSBC Perp 10/01/30

Hamilton Lane And 2 Additional Stocks Possibly Priced Below Their Estimated Value

Hamilton Lane (HLNE.US)

Hamilton Lane (HLNE) Q1 Earnings Report Preview: What To Look For

Assessing Hamilton Lane (HLNE) Valuation As New Interval Funds And Tokenization Expand Growth Channels

Oppenheimer & Co. Inc. Takes Position in Hamilton Lane Inc. $HLNE

MidOcean Announces Successful Close of Single-Asset Continuation Vehicle for Cloyes | HLNE Stock News

Asia private equity draws fresh investor interest as returns beat global averages, despite fundraising headwinds

Hamilton Lane Shares Slide Following Hunterbrook Short Report

Hamilton Lane And 2 Additional Stocks Possibly Priced Below Their Estimated Value

Trending